Medical Condition News

RSS

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

Boehringer Ingelheim today announced that both the U.S. Food and Drug Administration and the European Medicines Agency have accepted filing applications for afatinib for the treatment of patients with advanced squamous cell carcinoma (SCC) of the lung progressing after treatment with first-line chemotherapy.

26 Aug 2015

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

Clementia Pharmaceuticals, Inc. today announced the initiation of enrollment of children as young as 6 years old in the company's ongoing Phase 2 study of palovarotene for the treatment of fibrodysplasia ossificans progressiva (FOP).

26 Aug 2015

Chrono obtains second Fast Track SBIR grant award from NCI to support development of smoking cessation therapy

Chrono Therapeutics, a pioneer in digital drug therapy, today announced it has received a second Phase 1 and Phase 2 Fast Track Small Business Innovation Research (SBIR) grant award from the National Cancer Institute.

26 Aug 2015

Tocagen's Toca 511 & Toca FC receives FDA orphan drug designation for treatment of glioblastoma

Tocagen Inc., a clinical-stage immuno-oncology company, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to the company's lead immuno-oncology product candidate, Toca 511 & Toca FC, for the treatment of glioblastoma.

26 Aug 2015

First patient enrolled in CSL Behring's rVIIa-FP Phase II/III study to treat patients with hemophilia A or B with inhibitors

CSL Behring announced today that the first patient has been enrolled in its Phase II/III clinical study evaluating the pharmacokinetics (PK), efficacy, and safety of the company's recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) for on-demand treatment in patients with congenital hemophilia A or B who have developed an inhibitor to factor VIII or factor IX replacement therapy.

26 Aug 2015

Sequenom, UC San Diego Moores Cancer Center collaborate to explore utility of liquid biopsy assay

Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that it has entered into a clinical research collaboration with the University of California, San Diego Moores Cancer Center.

26 Aug 2015

Dexcom G5 Mobile Continuous Glucose Monitoring System receives FDA approval

Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that the U.S. Food and Drug Administration has approved the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System.

25 Aug 2015

Leukemia & Lymphoma Society to kick off 2015 Light The Night Walk campaign throughout Northern California

The Leukemia & Lymphoma Society will be kicking off its 2015 Light The Night Walk campaign throughout Northern California with the Napa Valley Walk on September 26, 2015 at 5 p.m. PT at Veterans Memorial Park.

25 Aug 2015

Special issue in Future Science OA explores nitric oxide in human medicine

Future Science Group today announced the publication of a special issue in Future Science OA, covering the rapidly evolving field of nitric oxide (NO) in human medicine.

25 Aug 2015

Irreversible electroporation may prolong survival rates of patients with locally advanced pancreatic cancer

Use of irreversible electroporation (IRE) doubles the survival time for patients with locally advanced pancreatic cancer say researchers at the University of Louisville in a paper in the September edition of the Annals of Surgery.

25 Aug 2015

Study shows significant link between macular pigment levels in the eye and cognitive function

Ongoing European Research Council-funded research at Waterford Institute of Technology's Macular Pigment Research Group is investigating the potential link between cognitive function and levels of a vital eye pigment linked to diet. The study suggests that measuring macular pigment offers potential as a biomarker of cognitive health

25 Aug 2015

Novel ESC paper highlights significance of e-health in tackling heart disease

E-health is vital to winning the battle against heart disease, European cardiology leaders said today in a European Society of Cardiology position paper published in European Heart Journal. The novel paper outlines how the ESC will exploit e-health in education and research, while tackling issues of quality control and data security.

25 Aug 2015

High dietary iron intake suppresses hormone that regulates appetite

Here's one more reason to cut down on the amount of red meat you eat. Using an animal model, researchers at Wake Forest Baptist Medical Center have found that dietary iron intake, equivalent to heavy red meat consumption, suppresses leptin, a hormone that regulates appetite.

25 Aug 2015

Mayo Clinic scientists discover potential way to reprogram cancer cells back to normalcy

Cancer researchers dream of the day they can force tumor cells to morph back to the normal cells they once were. Now, researchers on Mayo Clinic's Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.

25 Aug 2015

Researchers find way to screen blood samples to detect presence of precancerous polyps in the colon

Canadian researchers have found a way to screen blood samples for molecular traces that indicate the presence of precancerous polyps in the colon, a key warning sign for colon cancer. Their results, published this week in the journal Biomedical Optics Express, from The Optical Society, may yield a cheaper and less invasive initial screening test for colon cancer that could complement colonoscopy, though further clinical trials will need to demonstrate the safety and effectiveness of the blood test before it is routinely used.

25 Aug 2015

BET inhibitors can cause molecular changes in neurons, lead to memory loss in mice

Cancer researchers are constantly in search of more-effective and less-toxic approaches to stopping the disease, and have recently launched clinical trials testing a new class of drugs called BET inhibitors. These therapies act on a group of proteins that help regulate the expression of many genes, some of which play a role in cancer.

25 Aug 2015

Electronic triggers can help identify, reduce follow-up delays in evaluation for cancer diagnosis

Electronic triggers designed to search for key data, developed by researchers at Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, were able to identify and reduce follow-up delays for patients being evaluated for a diagnosis of colon or prostate cancer.

25 Aug 2015

FSU investigator solves cell division mystery

In the second part of his lab's recent one-two punch, Florida State University researcher Daniel Kaplan said he has solved a cell division mystery in a way that will intrigue the makers of cancer-fighting drugs.

25 Aug 2015

Researchers reveal new electrical mechanism that can control molecular switches regulating cancer cell growth

The molecular switches regulating human cell growth do a great job of replacing cells that die during the course of a lifetime. But when they misfire, life-threatening cancers can occur. Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.

25 Aug 2015

Karolinska Institutet study may lead to development of better immune-based cancer therapies

A study by researchers at Sweden's Karolinska Institutet is the first to suggest that cells in the tumour blood vessels contribute to a local environment that protects the cancer cells from tumour-killing immune cells. The results, which are being published in the 'Journal of the National Cancer Institute', can contribute to the development of better immune-based cancer therapies.

25 Aug 2015

Medical Condition News

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

Clementia expands enrollment to include children with FOP in ongoing Phase 2 clinical trial

Chrono obtains second Fast Track SBIR grant award from NCI to support development of smoking cessation therapy

Tocagen's Toca 511 & Toca FC receives FDA orphan drug designation for treatment of glioblastoma

First patient enrolled in CSL Behring's rVIIa-FP Phase II/III study to treat patients with hemophilia A or B with inhibitors

Sequenom, UC San Diego Moores Cancer Center collaborate to explore utility of liquid biopsy assay

Dexcom G5 Mobile Continuous Glucose Monitoring System receives FDA approval

Leukemia & Lymphoma Society to kick off 2015 Light The Night Walk campaign throughout Northern California

Special issue in Future Science OA explores nitric oxide in human medicine

Irreversible electroporation may prolong survival rates of patients with locally advanced pancreatic cancer

Study shows significant link between macular pigment levels in the eye and cognitive function

Novel ESC paper highlights significance of e-health in tackling heart disease

High dietary iron intake suppresses hormone that regulates appetite

Mayo Clinic scientists discover potential way to reprogram cancer cells back to normalcy

Researchers find way to screen blood samples to detect presence of precancerous polyps in the colon

BET inhibitors can cause molecular changes in neurons, lead to memory loss in mice

Electronic triggers can help identify, reduce follow-up delays in evaluation for cancer diagnosis

FSU investigator solves cell division mystery

Researchers reveal new electrical mechanism that can control molecular switches regulating cancer cell growth

Karolinska Institutet study may lead to development of better immune-based cancer therapies

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Latest News